Upgrade to SI Premium - Free Trial

Valeant Pharma (VRX) EBITDA Guidance Just Above Maintenance Covenants - Evercore ISI's Raffat

June 7, 2016 8:06 AM
Evercore ISI analyst Umer Raffat notes that Valeant Pharma (NYSE: VRX) EBITDA guidance was bit ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments Short Sales Trader Talk

Next Articles